# Exelixis, Inc.: filings

EXEL · Nasdaq · CIK 939767 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jan 1

Pages: [Overview](/companies/exel.md) · [Financials](/companies/exel/financials.md) · [Filings](/companies/exel/filings.md) · [Insiders](/companies/exel/insiders.md)

## Reports and events: 331 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 981, 8-K 221, SC 13G/A 87, 144 86, CT ORDER 64, 10-Q 54, S-8 POS 41, DEFA14A 22, 10-K 18, 3 17, DEF 14A 17, S-8 16, SC 13G 13, 424B5 12, ARS 10, 5 8, DFAN14A 8, SC 13D/A 6, 8-K/A 5, CORRESP 5, UPLOAD 5, 10-Q/A 4, 424B7 4, SCHEDULE 13D/A 4, POS AM 3, PRE 14A 3, S-3ASR 3, SCHEDULE 13G/A 3, SC TO-C 3, 424B3 2, 4/A 2, DEFC14A 2, EFFECT 2, PREC14A 2, SC 13D 2, SCHEDULE 13G 2, SC TO-I/A 2, 305B2 1, 3/A 1, AW 1, D 1, FWP 1, POSASR 1, PRRN14A 1, S-3 1, S-3/A 1, S-3MEF 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:16 ET | [10-Q](/filings/0000939767-26-000116.md) | Quarterly report, period 2026-10-02 | 0000939767-26-000116 |
| 2026-10-29 | 16:09 ET | [8-K](/filings/0000939767-26-000114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-26-000114 |
| 2026-09-11 | 07:00 ET | [8-K](/filings/0000939767-26-000108.md) | 8.01 Other events | 0000939767-26-000108 |
| 2026-08-31 | 16:18 ET | [8-K](/filings/0000939767-26-000104.md) | 8.01 Other events | 0000939767-26-000104 |
| 2026-08-14 | 08:21 ET | [SCHEDULE 13D/A](/filings/0000908834-26-000419.md) | Ownership report, active investor, amended | 0000908834-26-000419 |
| 2026-08-05 | 16:13 ET | [10-Q](/filings/0000939767-26-000098.md) | Quarterly report, period 2026-07-03 | 0000939767-26-000098 |
| 2026-08-05 | 16:09 ET | [8-K](/filings/0000939767-26-000096.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-26-000096 |
| 2026-05-29 | 16:05 ET | [8-K](/filings/0000939767-26-000074.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000939767-26-000074 |
| 2026-05-05 | 16:11 ET | [10-Q](/filings/0000939767-26-000059.md) | Quarterly report, period 2026-04-03 | 0000939767-26-000059 |
| 2026-05-05 | 16:07 ET | [8-K](/filings/0000939767-26-000058.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000939767-26-000058 |
| 2026-04-15 | 16:17 ET | [DEF 14A](/filings/0000939767-26-000046.md) | Proxy statement, period 2026-05-26 | 0000939767-26-000046 |
| 2026-02-10 | 16:32 ET | [10-K](/filings/0000939767-26-000021.md) | Annual report, period 2026-01-02 | 0000939767-26-000021 |
| 2026-02-10 | 16:08 ET | [8-K](/filings/0000939767-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-26-000019 |
| 2026-01-12 | 16:22 ET | [8-K](/filings/0000939767-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-26-000003 |
| 2026-01-05 | 18:05 ET | [SCHEDULE 13D/A](/filings/0000908834-26-000006.md) | Ownership report, active investor, amended | 0000908834-26-000006 |
| 2025-11-07 | 16:07 ET | [8-K](/filings/0000939767-25-000133.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0000939767-25-000133 |
| 2025-11-04 | 16:30 ET | [10-Q](/filings/0000939767-25-000128.md) | Quarterly report, period 2025-10-03 | 0000939767-25-000128 |
| 2025-11-04 | 16:25 ET | [8-K](/filings/0000939767-25-000127.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000939767-25-000127 |
| 2025-08-29 | 17:10 ET | [8-K](/filings/0000939767-25-000115.md) | 5.02 Departure or appointment of officers or directors | 0000939767-25-000115 |
| 2025-07-28 | 16:31 ET | [10-Q](/filings/0000939767-25-000113.md) | Quarterly report, period 2025-07-04 | 0000939767-25-000113 |
| 2025-07-28 | 16:09 ET | [8-K](/filings/0000939767-25-000111.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-25-000111 |
| 2025-06-02 | 16:05 ET | [8-K](/filings/0000939767-25-000097.md) | 5.07 Shareholder vote results | 0000939767-25-000097 |
| 2025-05-20 | 17:59 ET | [SCHEDULE 13D/A](/filings/0000908834-25-000192.md) | Ownership report, active investor, amended | 0000908834-25-000192 |
| 2025-05-13 | 16:14 ET | [10-Q](/filings/0000939767-25-000075.md) | Quarterly report, period 2025-04-04 | 0000939767-25-000075 |
| 2025-05-13 | 16:10 ET | [8-K](/filings/0000939767-25-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-25-000074 |
| 2025-04-16 | 16:27 ET | [DEF 14A](/filings/0000939767-25-000061.md) | Proxy statement, period 2025-05-28 | 0000939767-25-000061 |
| 2025-03-31 | 16:05 ET | [8-K](/filings/0000939767-25-000049.md) | 5.02 Departure or appointment of officers or directors | 0000939767-25-000049 |
| 2025-03-05 | 17:01 ET | [SCHEDULE 13D/A](/filings/0000908834-25-000094.md) | Ownership report, active investor, amended | 0000908834-25-000094 |
| 2025-02-21 | 08:00 ET | [8-K](/filings/0000939767-25-000032.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000939767-25-000032 |
| 2025-02-11 | 16:26 ET | [10-K](/filings/0000939767-25-000019.md) | Annual report, period 2025-01-03 | 0000939767-25-000019 |
| 2025-02-11 | 16:08 ET | [8-K](/filings/0000939767-25-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-25-000017 |
| 2025-01-13 | 16:34 ET | [8-K](/filings/0000939767-25-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-25-000004 |
| 2024-10-29 | 16:11 ET | [10-Q](/filings/0000939767-24-000150.md) | Quarterly report, period 2024-09-27 | 0000939767-24-000150 |
| 2024-10-29 | 16:07 ET | [8-K](/filings/0000939767-24-000149.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-24-000149 |
| 2024-10-15 | 16:15 ET | [8-K](/filings/0000939767-24-000140.md) | 8.01 Other events | 0000939767-24-000140 |
| 2024-10-15 | 08:00 ET | [8-K](/filings/0000939767-24-000138.md) | 8.01 Other events | 0000939767-24-000138 |
| 2024-08-06 | 16:18 ET | [10-Q](/filings/0000939767-24-000119.md) | Quarterly report, period 2024-06-28 | 0000939767-24-000119 |
| 2024-08-06 | 16:08 ET | [8-K](/filings/0000939767-24-000116.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000939767-24-000116 |
| 2024-06-03 | 17:21 ET | [8-K](/filings/0000939767-24-000081.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000939767-24-000081 |
| 2024-05-20 | 16:41 ET | [8-K](/filings/0000939767-24-000074.md) | 8.01 Other events | 0000939767-24-000074 |
| 2024-05-10 | 16:05 ET | [8-K](/filings/0000939767-24-000062.md) | 8.01 Other events | 0000939767-24-000062 |
| 2024-05-08 | 16:11 ET | [SC 13D/A](/filings/0000908834-24-000125.md) | Ownership report, active investor, amended | 0000908834-24-000125 |
| 2024-04-30 | 16:32 ET | [10-Q](/filings/0000939767-24-000058.md) | Quarterly report, period 2024-03-29 | 0000939767-24-000058 |
| 2024-04-30 | 16:12 ET | [8-K](/filings/0000939767-24-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-24-000054 |
| 2024-04-18 | 06:03 ET | [DEF 14A](/filings/0000939767-24-000044.md) | Proxy statement, period 2024-05-30 | 0000939767-24-000044 |
| 2024-03-29 | 16:14 ET | [8-K](/filings/0000939767-24-000040.md) | 5.02 Departure or appointment of officers or directors | 0000939767-24-000040 |
| 2024-02-06 | 16:49 ET | [10-K](/filings/0000939767-24-000028.md) | Annual report, period 2023-12-29 | 0000939767-24-000028 |
| 2024-02-06 | 16:28 ET | [8-K](/filings/0000939767-24-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939767-24-000025 |
| 2024-01-08 | 09:06 ET | [8-K](/filings/0000939767-24-000002.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000939767-24-000002 |
| 2023-12-20 | 16:20 ET | [8-K](/filings/0000939767-23-000127.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000939767-23-000127 |

Page 1 of 7. [Older](/companies/exel/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:46 ET. No prices; not investment advice.